ACADIA Pharmaceuticals Competitors and Similar CompaniesClear all
Neuraly's competitors and similar companies include Supernus Pharmaceuticals and Omeros.
 Neuraly Neuraly is a clinical-stage biotechnology company that specializes in the development of drugs for neurodegenerative diseases. |  Supernus Pharmaceuticals Supernus Pharmaceuticals is a specialty pharmaceutical company focused on developing and commercializing products for the treatment of central nervous system disorders. |  Omeros Omeros Corporation is a biopharmaceutical company developing products focused on inflammation and central nervous system disorders as well as immune-related diseases, including cancers. | |
Founding Date | Founding Date 2016 | Founding Date 2005 | Founding Date 1994 |
Type | Type Subsidiary | Type Public | Type Public |
Tags | |||
Locations | Locations Gaithersburg, US HQ | Locations Rockville, US HQ | Locations Seattle, US HQ |
Employees | Employees 186% increase | Employees 6527% increase | Employees 1968% decrease |
Valuation ($) | Valuation ($) N/A | Valuation ($) 1.9 b | Valuation ($) 248.6 m |
Financial | |||
Net income | Net income N/A | Net income ($38.6m) (FY, 2025) | Net income ($3.4m) (FY, 2025) |
Funding | |||
Total funding raised | Total funding raised $ 36m | Total funding raised $ 69.5m | Total funding raised $ 354.8m |
For sources of this data, please see the company profile
View Company Profiles
Supernus Pharmaceuticals
HQ
Rockville, US
Employees
652↑ 7% increase
Supernus Pharmaceuticals is a specialty pharmaceutical company focused on developing and commercializing products for the treatment of central nervous system disorders.
View companyOmeros
HQ
Seattle, US
Employees
196↓ 8% decrease
Omeros Corporation is a biopharmaceutical company developing products focused on inflammation and central nervous system disorders as well as immune-related diseases, including cancers.
View company